Focus Financial Network Inc. Has $1.05 Million Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Focus Financial Network Inc. reduced its position in iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 7,901 shares of the financial services provider’s stock after selling 87 shares during the period. Focus Financial Network Inc.’s holdings in iShares Biotechnology ETF were worth $1,045,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Valeo Financial Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the third quarter worth approximately $206,000. Prism Advisors Inc. acquired a new stake in iShares Biotechnology ETF during the 3rd quarter worth $206,000. SeaCrest Wealth Management LLC raised its position in shares of iShares Biotechnology ETF by 203.7% during the 3rd quarter. SeaCrest Wealth Management LLC now owns 10,213 shares of the financial services provider’s stock valued at $1,487,000 after acquiring an additional 6,850 shares during the last quarter. SPC Financial Inc. raised its position in shares of iShares Biotechnology ETF by 2.4% during the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after acquiring an additional 75 shares during the last quarter. Finally, Good Life Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 59.4% in the 3rd quarter. Good Life Advisors LLC now owns 2,666 shares of the financial services provider’s stock valued at $388,000 after purchasing an additional 993 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.9 %

Shares of iShares Biotechnology ETF stock opened at $135.47 on Thursday. The business has a fifty day simple moving average of $135.88 and a 200 day simple moving average of $141.13. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.